EII Capital Management’s Healthcare Realty HR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-22,063
Closed -$654K 80
2021
Q3
$654K Sell
22,063
-2,052
-9% -$59.8K 0.31% 84
2021
Q2
$644K Sell
24,115
-1,187
-5% -$33.6K 0.3% 86
2021
Q1
$698K Sell
25,302
-7,292
-22% -$204K 0.36% 74
2020
Q4
$898K Sell
32,594
-1,798
-5% -$47.4K 0.51% 56
2020
Q3
$894K Sell
34,392
-300
-0.9% -$7.87K 0.57% 49
2020
Q2
$920K Buy
34,692
+700
+2% +$17.9K 0.6% 47
2020
Q1
$825K Buy
33,992
+2,557
+8% +$77.3K 0.55% 56
2019
Q4
$952 Buy
31,435
+739
+2% +$22.1K 0.27% 71
2019
Q3
$902 Sell
30,696
-1,077
-3% -$30.1K 0.25% 78
2019
Q2
$872K Buy
31,773
+5,203
+20% +$147K 0.47% 73
2019
Q1
$760K Sell
26,570
-3,957
-13% -$110K 0.42% 81
2018
Q4
$773K Buy
30,527
+1,243
+4% +$32.9K 0.44% 73
2018
Q3
$783K Buy
29,284
+4,509
+18% +$124K 0.43% 75
2018
Q2
$668K Hold
24,775
0.36% 83
2018
Q1
$655K Sell
24,775
-2,295
-8% -$61.1K 0.38% 83
2017
Q4
$813K Sell
27,070
-18,024
-40% -$545K 0.34% 93
2017
Q3
$1.34M Buy
+45,094
New +$1.37M 0.5% 75

Other funds holding HR

EII Capital Management's HR Position: Q4 2021 in Review

EII Capital Management sold out of Healthcare Realty (HR) in Q4 2021, closing a stake of 22,063 shares — an estimated $654K sold.

EII Capital Management first reported a position in HR in Q3 2017 and held it in 17 quarters. The position peaked at $1.34M in Q3 2017. 386 funds tracked by Wall St. Rank hold HR as of Q4 2021.

  • EII Capital Management reported no remaining Healthcare Realty position as of Q4 2021 after selling out during the quarter.
  • EII Capital Management sold 22,063 Healthcare Realty shares in Q4 2021, an estimated $654K.
  • EII Capital Management first reported a position in Healthcare Realty in Q3 2017 and held it in 17 quarters.
  • EII Capital Management's Healthcare Realty position peaked at $1.34M in Q3 2017.
  • 386 funds tracked by Wall St. Rank held Healthcare Realty as of Q4 2021.

Based on EII Capital Management's 13F filing for Q4 2021, filed 21 Jan 2022.